<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>Evidence for HIV Prevention in Southern Africa</institution>
  </funding-source>
  <award-id>MM/EHPSA/WHC/0116029</award-id>
  <principal-award-recipient>
   <name>
    <surname>Palanee-Phillips</surname>
    <given-names>Thesla</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This study was funded through the Evidence for HIV prevention in Southern Africa (EHPSA) programme (
  <ext-link ext-link-type="uri" xlink:href="http://www.ehpsa.org/" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.ehpsa.org/</ext-link>, grant number MM/EHPSA/WHC/0116029, PI Thesla Palanee-Phillips) funded by UK aid from the Department for International Development, and Sweden, through the Swedish International Development Agency (SIDA), mandated to represent the Norwegian Agency for Development Cooperation (Norad), and managed by Mott Macdonald. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
 </funding-statement>
</funding-group>
